drugset / Trial / NCT03219203

Immunologic Response of Hepatitis B Vaccine

NCT03219203

Phase 4 Unknown 80 enrolled Chiang Mai University
RandomizedParallel-groupOpen-labelPrevention

Summary

This study aims to evaluate the immunologic response to the two hepatitis B virus (HBV) vaccination booster strategies in previously vaccinated HIV-infected adults at Maharaj Nakorn Chiang Mai Hospital.

Timeline

Start
2017-07-01
Primary completion
2018-07-01
Completion
2018-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Hepatitis B vaccine Vaccine 20 ug Intramuscular